1) L-OHP
奥沙利铂
1.
Anti-tumor effects of L-OHP and CIK cells on transplantable peritoneal metastasis of human gastric cancer in nude mice;
奥沙利铂结合CIK细胞对人胃癌裸鼠腹膜移植模型体内抗肿瘤作用的实验研究
2.
Objective To evaluate tha effects of L-OHP and Capecitabine on terminal advanced colorected carcinoma.
目的观察奥沙利铂(L-OHP)联合卡培他滨治疗晚期大肠癌的疗效和毒副反应。
3.
Objective: To establish the determination method of L-OHP in vivo and in vitro by HPLC, to considerate the security of L-OHP administrating in heated intra-operative intra-peritoneal therapy of digestive system neoplasm s patients.
目的:运用HPLC分别建立奥沙利铂(L-OHP)体外、体内测定方法,以研究L-OHP用于消化系统肿瘤患者术中腹腔热灌注的安全性考察;测定肿瘤患者两种给药方案下静脉输注不同剂量时L-OHP体内药代动力学参数,监测体内血浆蛋白结合铂的变化情况。
2) L-OHP
草酸铂
1.
Clinical Observation of Docetaxel Combined with L-OHP and Xeloda in the Treatment of Advanced Gastric Cancer;
多烯紫杉醇联合草酸铂并口服卡培他滨治疗晚期胃癌临床观察
2.
The effect of treatment of Metastatic carcinoma of the colon and rectum using L-OHP and timing 5-Fu/CF;
草酸铂与时间调节5-氟脲嘧啶/亚叶酸钙治疗转移性结直肠癌疗效
3) L-OHP
L-OHP
1.
Objective To observe the efficacy,toxicity and patients acceptance of L-OHP+5-Fu+CF and 5-Fu+CF in postoperative period of advanced colorectal cancer.
目的观察L-OHP+5-Fu+CF与5-Fu+CF两种化疗方案的疗效和毒副反应,及患者对两种方案的接受程度。
2.
Methods:20 cases were randomly divided into two groups:Group A(experimental group),whose patients received intravenous drip with the L-OHP dosage by 130 mg/m~2 on the first day,along with the CF dosage by 200 mg/m~2 and 5-Fu dosage by 500 mg/m~2 from 1st to 5th day;Group B (control group),whose patients received intravenous drip with the CF dosage by 200 mg/m~2 and 5-Fu dosage by 500 m.
方法:20例晚期大肠癌患者随机分为治疗组和对照组,A组(治疗组)L-OHP130mg/m2静滴第1天,亚叶酸钙(CF)200mg/m2,第1~5天,静滴,5-氟脲嘧啶(5-Fu)500mg/m2,静滴1~5天,21天为一疗程;B组(对照组):CF200mg/m2,第1~5天静滴,5-Fu500mg/m2,静滴1~5天,21天为一疗程,2疗程后评定疗效。
4) Oxaliplatin(L-OHP)
草酸铂
1.
Objective To evaluate the near therapeutic effect and toxicity of civcombination with chemotherapy oxaliplatin(L-OHP),calcium folinate(CF) and 5-Fluorouracil(5-Fu) on rectum carcinoma.
目的评价草酸铂(L-OHP)联合亚叶酸钙(CF)和氟尿嘧啶(5-Fu)时辰化疗方案治疗直肠癌近期疗效和毒副作用。
2.
Clinical Observation of Oxaliplatin(L-OHP)Combined with Leucovorin and 5-fluorouracil for the Treatment of 37 Patients with Advanced Gastric Carcinoma;
目的:观察草酸铂(艾恒)联合亚叶酸钙和5-Fu组成的FOLFOX4方案治疗晚期胃癌的疗效和毒副反应。
5) LF+L-OHP
LF+L-OHP
1.
Comparative study between LF-DDP and LF+L-OHP in chemotherapy for advanced gastric adenocarcinoma;
LF+DDP和LF+L-OHP方案在晚期胃腺癌化疗中的对照观察
6) L-OHP+5-Fu/LV
草酸铂+5-Fu/LV方案
1.
Objective: According to the pathogenic peculiarity of weak in spleen function combined with qi deficiency,“jian pi yi qi fa”based on the therapeutic principle of promoting qi and strengthen spleen was studied out for cancer of colon, combined with chemotherapy (L-OHP+5-Fu/LV regimen) to observe the effect of the treatment with integrated traditional Chinese and western medicine on CRC.
方法:将43例大肠癌住院患者,随机分为两组,其中观察组23例,对照组20例,两组均给予草酸铂+5-Fu/LV方案化疗,观察组加服健脾化积方并随证加减。
参考词条
补充资料:奥沙利铂
分子式:C8H12N2O4Pt
分子量:暂无
CAS号:61825-94-3
性质:暂无
制备方法:暂无
用途:抗肿瘤药。
分子量:暂无
CAS号:61825-94-3
性质:暂无
制备方法:暂无
用途:抗肿瘤药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。